Pfizer (Australia) ETOPOSIDE 20mg/mL injection vial multidose Australien - engelsk - Department of Health (Therapeutic Goods Administration)

pfizer (australia) etoposide 20mg/ml injection vial multidose

pfizer australia pty ltd - etoposide, quantity: 20 mg/ml - injection, concentrated - excipient ingredients: macrogol 300; citric acid; polysorbate 80; ethanol absolute - indications as at 3 april 1996: etoposide injection is indicated for the following: small cell carcinoma of the lung. acute monocytic and myelomonocytic leukaemia. hodgkin's disease. non-hodgkin's lymphoma

Etoposide 50 mg capsule, soft Malta - engelsk - Medicines Authority

etoposide 50 mg capsule, soft

p & d pharmaceuticals limited 38 woolmer way, bordon hampshire gu35 9qf, united kingdom - etoposide - soft capsule - etoposide 50 mg - antineoplastic agents

Etoposide 20mg/ml Concentrate for solution for infusion Malta - engelsk - Medicines Authority

etoposide 20mg/ml concentrate for solution for infusion

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - etoposide - concentrate for solution for infusion - etoposide 20 mg/ml - antineoplastic agents

Etoposide Sandoz 20mg/ml Malta - engelsk - Medicines Authority

etoposide sandoz 20mg/ml

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - etoposide - concentrate for solution for infusion - etoposide 20 mg/ml - antineoplastic agents

ETOPOSIDE TEVA 20 mg/ml, concentrate for solution for infusion. Malta - engelsk - Medicines Authority

etoposide teva 20 mg/ml, concentrate for solution for infusion.

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - etoposide - concentrate for solution for infusion - etoposide 20 mg/ml - antineoplastic agents

Etoposide Ebewe 20 mg/ml, concentrate for solution for infusion Malta - engelsk - Medicines Authority

etoposide ebewe 20 mg/ml, concentrate for solution for infusion

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - etoposide - concentrate for solution for infusion - etoposide 20 mg/ml - antineoplastic agents

Gemcitabine 40mg/ml concentrate for solution for Infusion Irland - engelsk - HPRA (Health Products Regulatory Authority)

gemcitabine 40mg/ml concentrate for solution for infusion

fresenius kabi oncology plc - gemcitabine hydrochloride - concentrate for solution for infusion - 40 milligram(s)/millilitre - pyrimidine analogues; gemcitabine

Gemcitabine 38mg/ml Concentrate for Solution for Infusion Irland - engelsk - HPRA (Health Products Regulatory Authority)

gemcitabine 38mg/ml concentrate for solution for infusion

fresenius kabi oncology plc - gemcitabine hydrochloride - concentrate for solution for infusion - 38 milligram(s)/millilitre - pyrimidine analogues; gemcitabine

Gemcitabine 40 mg/ml concentrate for solution for Infusion Irland - engelsk - HPRA (Health Products Regulatory Authority)

gemcitabine 40 mg/ml concentrate for solution for infusion

fresenius kabi deutschland gmbh - gemcitabine - concentrate for solution for infusion - 40 milligram(s)/millilitre - pyrimidine analogues; gemcitabine

Etoposide Australien - engelsk - Department of Health (Therapeutic Goods Administration)

etoposide

sandoz pty ltd - etoposide -